Partners In Investing

What creates a durable edge in systematic equity investing? GMO examines the research, valuation framework, and portfolio construction behind its approach.

As the Goldilocks era ends, liquidity and true diversification matter more. GMO explores why liquid alternatives deserve a fresh look.

Surging electricity demand is reshaping the energy landscape, creating opportunities for investors across a wide variety of industries.

In GMO’s latest Quarterly Valuation Update, FX and local currency rates screen cheap and very cheap, while hard currency credit is rich.

GMO's 7-Year Asset Class Forecast as of June 30, 2026.

Emerging market debt is broad and inefficient. We examine when a total return, cash‑plus approach may better align portfolios with desired outcomes.

GMO's Equity Dislocation Strategy has gotten off to a strong start in H1 2026. Our mid-year update explores how valuation discipline and active rotation shaped performance amid AI-driven volatility.

Japan’s corporate governance reforms are entering a new phase aimed squarely at how companies put capital to work. We examine what that means for investors and why active engagement still matters.

Structural reforms, rising earnings, and attractive valuations suggest Japanese equities still offer meaningful upside despite strong recent returns.

Many still treat 60/40 as a neutral starting point. But after years of market gains, that “default” mix can embed unintended concentration in expensive U.S. growth and credit risk with limited spread cushion.

Research shows that private equity portfolios skew toward smaller, lower-quality companies, increasing downside risk. Ben Inker and John Pease explain how to hedge the resulting bias more effectively.

Ben Inker pens a letter to the Investment Committee addressing the erosion of private equity performance persistence and its implications for institutions with meaningful private equity exposure.